{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:08:15Z","timestamp":1793714895272,"version":"4.6.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cardiovascular disease commonly affects advanced liver disease patients. They undergo cardiac interventions to improve cardiac outcomes. Cirrhosis increases complication risk, including bleeding, renal and respiratory failure, and further decompensation, including death, posing a clinical dilemma to proceduralists. Predicting outcomes is crucial in managing patients with cirrhosis. Our aim was to systematically review clinical parameters to assess the mortality and complication risk in patients with cirrhosis undergoing cardiac interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We searched cirrhosis and cardiovascular intervention terminology in PubMed and Excerpta Medica Database (EMBASE) from inception to January 8, 2023. We included studies reporting clinical scores (e.g. Model for End-stage Liver Disease (MELD), Child\u2013Pugh\u2013Turcotte (CPT), cardiovascular interventions, mortality, and morbidity outcomes). We independently abstracted data from eligible studies and performed qualitative summaries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Eight studies met the inclusion criteria. Procedures included tricuspid valve surgery, catheterization-related procedures, aortic valve replacement (AVR), pericardiectomy, and left ventricular assist device (LVAD) placement. MELD primarily predicted mortality (n = 4), followed by CPT (n = 2). Mortality is significantly increased for MELD &gt; 15 after tricuspid valve surgery. Albumin, creatinine, and MELD were significantly associated with increased mortality after transcatheter AVR (TAVR), although specific values lacked stratification. CPT was significantly associated with increased mortality after cardiac catheterization or pericardiectomy. In LVAD placement, increasing MELD increased the unadjusted odds for perioperative mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our systematic review showed that clinical parameters predict mortality and morbidity risk in patients with cirrhosis undergoing cardiac procedures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjg.sjg_263_23","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T06:02:26Z","timestamp":1700546546000},"page":"14-22","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Using noninvasive clinical parameters to predict mortality and morbidity after cardiac interventions in patients with cirrhosis: A systematic review"],"prefix":"10.4103","volume":"30","author":[{"given":"Christo","family":"Mathew","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Cholankeril","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA"},{"name":"Department of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine, Baylor St. Luke\u2019s Medical Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avegail","family":"Flores","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA"},{"name":"Department of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine and Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Hernaez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA"},{"name":"Department of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine and Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,18]]},"reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum:From obesity to metabolic syndrome and diabetes","volume":"12","author":"Godoy-Matos","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"R2-20240829","first-page":"1036","article-title":"Ischemic heart disease and liver cirrhosis:Adding insult to injury","volume":"12","author":"G\u00eerleanu","year":"2022","journal-title":"Life (Basel)"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11748-022-01797-4","article-title":"Helpfulness of the liver disease scores in cardiac surgery for cirrhotic patients","volume":"70","author":"Sebestyen","year":"2022","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.14309\/00000434-201010001-00246","article-title":"Complication rates after cardiac catheterization in patients with cirrhosis:246","volume":"105","author":"Narang","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ccd.22591","article-title":"Cardiac catheterization in patients with end-stage liver disease:Safety and outcomes","volume":"77","author":"Pillarisetti","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/lt.26060","article-title":"External validation of the VOCAL-Penn Cirrhosis surgical risk score in 2 large, independent health systems","volume":"27","author":"Mahmud","year":"2021","journal-title":"Liver Transpl"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ijcard.2016.11.096","article-title":"Prognostic value of liver dysfunction assessed by MELD-XI scoring system in patients undergoing transcatheter aortic valve implantation","volume":"228","author":"Arai","year":"2017","journal-title":"Int J Cardiol"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/24748706.2019.1595237","article-title":"Impact of liver cirrhosis on early and midterm results after transcatheter aortic valve replacement:A retrospective, observational study","volume":"3","author":"Nakamura","year":"2019","journal-title":"Struct Heart"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/hep.31193","article-title":"Long-term outcomes after transcatheter and surgical aortic valve replacement in patients with cirrhosis:A guide for the hepatologist","volume":"72","author":"Peeraphatdit","year":"2020","journal-title":"Hepatology"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/apt.14121","article-title":"Patients with cirrhosis who have coronary artery disease treated with cardiac stents have high rates of gastrointestinal bleeding, but no increased mortality","volume":"46","author":"Krill","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.amjcard.2012.05.043","article-title":"Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization","volume":"110","author":"Townsend","year":"2012","journal-title":"Am J Cardiol"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.athoracsur.2013.06.016","article-title":"Child-Pugh score predicts survival after radical pericardiectomy for constrictive pericarditis","volume":"96","author":"Komoda","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCULATIONAHA.108.838656","article-title":"Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality","volume":"121","author":"Matthews","year":"2010","journal-title":"Circulation"},{"key":"R14-20240829","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.athoracsur.2009.01.043","article-title":"Model for end-stage liver disease predicts mortality for tricuspid valve surgery","volume":"87","author":"Ailawadi","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"e2877","DOI":"10.1097\/MD.0000000000002877","article-title":"Child-pugh versus MELD score for the assessment of prognosis in liver cirrhosis:A systematic review and meta-analysis of observational studies","volume":"95","author":"Peng","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R16-20240829","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1053\/j.gastro.2021.08.015","article-title":"AGA Clinical practice guidelines on the management of coagulation disorders in patients with cirrhosis","volume":"161","author":"O'Shea","year":"2021","journal-title":"Gastroenterology"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease:Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2017","journal-title":"Hepatology"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0:The model for end-stage liver disease updated for the modern era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_263_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:25:54Z","timestamp":1786724754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_263_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,18]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_263_23","relation":{},"ISSN":["1319-3767","1998-4049"],"issn-type":[{"value":"1319-3767","type":"print"},{"value":"1998-4049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,18]]},"assertion":[{"value":"2023-07-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}